Publication Date
12-1-2024
Journal
JAAD International
DOI
10.1016/j.jdin.2024.07.012
PMID
39399340
PMCID
PMC11471237
PubMedCentral® Posted Date
8-16-2024
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Keywords
pediatric dermatology, psychiatric comorbidities, psychodermatology, skin of color, vitiligo
Abstract
BACKGROUND: Vitiligo may impact psychosocial development, especially among African American pediatric patients, given heightened visibility and increasing rates of anxiety and depression in this subpopulation.
OBJECTIVE: Evaluate psychiatric comorbidities and treatment initiation in African American pediatric patients.
METHODS: A total of 327 African American pediatric patients with vitiligo were each matched to 3 patients without vitiligo by age, race, and sex in this case-control study. Prevalence of psychiatric conditions and subsequent initiation of pharmacotherapy and/or psychotherapy were analyzed.
RESULTS: Compared to controls, pediatric African American patients with vitiligo were significantly more likely to be diagnosed with depression (
LIMITATIONS: This retrospective study has a limited sample size in a single institution and does not explore psychiatric treatment efficacy.
CONCLUSIONS: Better understanding of associated psychological comorbidities and impacts on African American children of vitiligo may improve quality of life and dermatologic outcomes for these individuals.
Included in
Dermatology Commons, Medical Sciences Commons, Mental and Social Health Commons, Pediatrics Commons, Psychiatry and Psychology Commons, Race and Ethnicity Commons, Skin and Connective Tissue Diseases Commons